24.9 C
New York
Tuesday, June 6, 2023

Analysts Point To Quest Diagnostics Incorporated (NYSE: DGX) Growth In The Future

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Quest Diagnostics Incorporated (DGX) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$1.90, or -1.44%, to $130.50. The Quest Diagnostics Incorporated has recorded 22,213 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Quest’s State-of-the-Art Laboratory in Clifton, NJ Hosts American Heart Association’s Hispanic Serving Institutions Scholars Program.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


Stocks Info

As a NYSE listed company, DGX falls under the Healthcare sector while operating within the Diagnostics & Research industry segment. At the end of the last regular session, the stock closed at $132.40 and fluctuated between $132.66 as its day high and $130.10 as its day low. The current market capitalization of Quest Diagnostics Incorporated is $14.85B. A total of 0.75 million shares were traded on the day, compared to an average of 1.13M shares.

Insider Activity

Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, DGX has seen 17 BUY and 29 SELL insider trades, representing the acquisition of 179,670 and the disposition of 87,323 shares. Over the last 12 months, there were 52 BUYs and 54 SELLs from insiders. Insiders purchased 707,890 shares during that period but sold 590,987.

In the most recent transaction, Doherty Catherine T. sold 5,307 shares of DGX for 140.55 per share on Mar 07. After the transaction, the SVP, Regional Businesses now owns 67,810 company shares. In a previous transaction on Mar 07, PREVOZNIK MICHAEL E sold 4,754 shares at 140.55 per share. DGX shares that SVP & General Counsel owns now total 38,527.

Among the insiders who sold shares, Doherty Catherine T. disposed of 717 shares on Mar 03 at a per-share price of $140.63. This resulted in the SVP, Regional Businesses holding 67,810 shares of DGX after the transaction. In another insider transaction, PREVOZNIK MICHAEL E sold 593 shares at $138.54 per share on Mar 02. Company shares held by the SVP & General Counsel now total 38,527.


Investors prefer companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook. Quest Diagnostics Incorporated pays an annual dividend of $2.84, resulting in a dividend yield of 2.15%, and it has a price to earnings (P/E) ratio of 19.56. DGX’s most recent ex-dividend date was 4/6/2023 when it declared a $0.71 quarterly dividend that was paid in cash on 4/24/2023. Previously, the company paid the dividend on 2/1/2023 with an ex-dividend date of 1/17/2023. The DGX stock dividend was $0.66 per share in cash.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for DGX in the last 3 months, the mean price target is $148.14 with high estimates of $165.00 and low estimates of $140.00. In terms of 52-week highs and lows, DGX has a high of $158.34 and a low of $120.40.

As of this writing, DGX has an earnings estimate of $2.27 per share for the current quarter. EPS was calculated based on a consensus of 13 estimates, with a high estimate of $2.39 per share and a lower estimate of $2.11. The company reported an EPS of $1.98 in the last quarter, which was 3.70% higher than expectations of $1.91.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. DGX’s latest balance sheet shows that the firm has $872.00M in Cash & Short Term Investments as of fiscal 2021. There were $4.66B in debt and $1.75B in liabilities at the time. Its Book Value Per Share was $54.02, while its Total Shareholder’s Equity was $6.56B.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DGX is Buy with a score of 3.36.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles